The work to bring the conference to Gothenburg has been a collaborative effort, involving, among others, AstraZeneca, RISE Research Institutes of Sweden, ATMP Sweden, Göteborg & Co and Business Region Göteborg.
The announcement of the 2024 meeting followed announcement from the Swedish government of a new national centre for the commercialisation, competence development and production of advanced therapies – CCRM Nordics – to be located at GoCo Health innovation City in Gothenburg.
The local organising group is currently working with the ISCT planning committee to broaden the scope of the program to attract additional ATMP stakeholders, including analytics, quality and clinical toxicity.